DC Politics DC
Gilead Sciences buying Forty Seven for $4.9 billion
Gilead Sciences is buying the cancer treatment company Forty Seven in a deal valued at approximately $4.9 billion. Gilead, based in Foster City, California, will pay $95.50 for eac…
